Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients

Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients

Abstract Background After successful of antiretroviral therapy, highly effective direct acting antiviral (DAA) make HCV elimination reasonable in HIV/HCV co-infected patients. However, in achieving this target, there are still barriers to start DAA treatment, particularly in the area of liver fibros...

Full description

Bibliographic Details
Main Authors: Evy Yunihastuti, Bramantya Wicaksana, Andrian Wiraguna, Ainum Jhariah Hidayah, Fhadilla Amelia, Veritea Natali, Alvina Widhani, Andri Sanityoso Sulaiman, Juferdy Kurniawan
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Infectious Diseases
Subjects:
APRI
FIB-4
Transient elastography
HIV
HCV
Online Access:http://link.springer.com/article/10.1186/s12879-020-05069-5

Internet

http://link.springer.com/article/10.1186/s12879-020-05069-5

Similar Items